Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis

Journal of Medical Virology

Volumn 51, Issue 4, 1997, Pages 313-318

  Zignego, Anna Linda ^a,c   Fontana, Rossana ^a   Puliti, Silvia ^a   Barbagli, Susanna ^a   Monti, Monica ^a   Careccia, Grazia ^a   Giannelli, Francesca ^a   Giannini, Carlo ^a   Buzzelli, Giampiero ^a   Brunetto, Maurizia Rossana ^b   Bonino, Ferruccio ^b   Gentilini, Paolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c Dipartimento di Medicina Interna   (Italy)

Author keywords

Double infection; HBV; HCV; IFN treatment

Indexed keywords

ALPHA INTERFERON; RECOMBINANT ALPHA2A INTERFERON;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; POLYMERASE CHAIN REACTION; PROGNOSIS; VIRUS DETECTION; VIRUS INTERFERENCE; VIRUS REPLICATION;

ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; CHRONIC DISEASE; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; RNA, VIRAL;

EID: 0030938308     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199704)51:4<313::AID-JMV9>3.0.CO;2-8     Document Type: Article

References (39)

1. Alberti A, Chemello L, Bonetti P (1992): Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. Journal of Hepatology 17:S123-S126.
2. Brunetto MR, Arrigoni A, Toti M, Almi P, Zanetti A, Ferroni P, Doris R (1988): The diagnostic significance of IgM antibody to hepatitis B core antigen, revisited. Italian Journal of Gastroenterology 20: 167-170.
3. Brunetto MR, Torrani Cerenzia M, Olivieri F, Piantino P, Randone A, Calvo PL, Manzini P, Rocca G, Galli C, Bonino F (1993): Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. Journal of Hepatology 19:431-436.
4. Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW (1990): Hepatitis C virus: The major causative agent of viral non-A, non-B hepatitis. British Medical Bulletin 46:423-441.
5. Colloredo Mels G, Bellati G, Leandro G, Brunetto MR, Vicari O, Piantino P, Borzio M, Angeli G, Ideo G, Bonino F (1993): Role of IgM antibody to hepatitis B core antigen in the diagnosis of hepatitis B exacerbations. Archives of Virology S8:203-211.
6. Colloredo Mels G, Bellati G, Leandro G, Brunetto MR, Vicari O, Borzio M, Piantino P, Fornaciari G, Scudeller G, Angeli A, Bonino F, Ideo G (1994): Fluctuations of viremia, aminotransferase and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbation. Liver 14:175-181.
7. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner JG, Goodman Z (1989): Recombinant interferon alpha therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial. New England Journal of Medicine 321: 1506-1510.
8. Farci P, Mandas A, Coiana A, Lai ME, Desmet V, Van Eyken P, Gibo Y, Caruso L, Scaccabarozzi S, Criscuolo D, Ryff JC, Balestrieri A (1994): Treatment of chronic hepatitis D with interferon alpha-2a. New England Journal of Medicine 330:88-94.
9. Fattovich G, Brollo L, Boscaro S, Pontisso P, Giustina G, Criscuolo D, Maladorno D, Alberti A, Realdi G, Ruol A (1989): Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B. Journal of Hepatology 9:331-337.
10. Feray C, Zignego AL, Samuel D, Bismuth A, Reynes M, Tiollais P, Bismuth H, Brechot C (1990): Persistent hepatitis B virus infection of mononuclear blood cells without concomitant liver infection. Transplantation 49:1155-60.
11. Ferri C, Marzo E, Longobardo G, Lombardini F, La Civita L, Bombardieri S, Zignego AL (1993): Alpha-interferon in mixed cryoglobulinemia patients: A randomized crossover controlled trial. Blood 81:1132-1136.
12. Garson JA, Brillanti S, Whitby K, Foli M, Deaville R, Masci C, Miglioli M, Barbara L (1995): Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C. Journal of Medical Virology 45:348-353.
13. Gerlich GH, Uy A, Lambrecht F, Thomssen R (1986): Cut-off levels of IgM antibody against viral core antigen for differentiation of acute, chronic and past hepatitis B virus infection. Journal of Clinical Microbiology 24:288-293.
14. Hoofnagle JH, Mullen KD, Jones DB, Di Bisceglie A, Peters M, Waggoner JG (1987): Treatment of chronic non-A, non-B hepatitis with recombinant human alpha-interferon. A preliminary report. New England Journal of Medicine 315:1575-1578.
15. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H (1993): A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 18:47-53.
16. Koretz RL, Stone O, Mousa M, Gitnick GL (1985): The NANB post-transfusion hepatitis. A decade later. Gastroenterology 88:1251-1254.
17. Lau Jyn W, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC (1993): Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 341:1501-1504.
18. Liaw Yun-Fan (1995): Role of Hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 22:1101-1108.
19. Magrin S, Craxi A, Fabiano C, Simonetti RG, Florentine G, Marino A, Diquattro O, Di Marco V, Loiacono O, Volpes R, Almasio P, Urdea MS, Neuwald P, Sancez-Pescador R, Detmer J, Wilber JC, Pagliaro L (1994): Hepatitis C viremia in chronic liver disease: Relationship to interferon-α or corticosteroid treatment. Hepatology 19:273-279.
20. Marinos G, Smith HM, Naoumov NV, Williams R (1994): Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection. Hepatology 19:303-311.
21. 2a therapy in patients with chronic hepatitis C. Digestive Diseases and Sciences 39:1273-1280.
22. Okada SI, Akahane Y, Suzuki H, Okamoto H, Mishiro S (1992): The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16:619-624.
23. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M (1992): Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J Gen Virol 73:673.
24. Ounanian A, Gueddah N, Rolachon A, Thelu MA, Zarski JP, Seigneurin JM (1995): Hepatitis C virus RNA in plasma and blood mononuclear cells in patients with chronic hepatitis C treated with alpha-interferon. Journal of Medical Virology 45:141-145.
25. Perillo RP (1989): Interferon therapy for chronic type B hepatitis: The promise comes of age. Gastroenterology 96:532-536.
26. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A (1993): Clinical and virological profiles in patients with multiple hepatitis virus infection. Gastroenterology 105: 1529-1533.
27. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A (1994): Clinical and virological profiles in patients with multiple hepatitis virus infection. Gastroenterology 107:322-323.
28. Pozzato G, Kaneko S, Moretti M, Crocè LS, Franzin F, Unoura M, Bercih L, Tiribelli C, Crovatto M, Santini G, Kobayashi K (1994): Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. Journal of Medical Virology 43:291-296.
29. Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, Prieto J (1992): Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 16:637-641.
30. Scotto J, Hadchouel M, Hery C, Yvart J, Tiollais P, Brechot C (1983): Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: Comparison with results of other viral markers. Hepatology 3:279-284.
31. Serfaty L, Giral P, Loria A, Andreani T, Legendre C, Poupon R (1994): Factors predictive of the response to interferon in patients with chronic hepatitis C. Journal of Hepatology 21:12-17.
32. Suzuki T, Tanaka E, Matsumoto A, Urushihara A, Sodeyama T (1995): Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon α2a therapy. Journal of Medical Virology 46:162-168.
33. Thiers V, Nakajima E, Krensdorf D, Macke D, Schellekens H, Driss F, Goudeau A (1988): Detection and cloning by the polymerase chain reaction of hepatitis B virus (HBV) DNA sequences in blood samples negative for HBV serologic markers. Lancet 2:1273-1276.
34. Weltman WD, Brotodihardjo A, Crewe EB, Farrell GC, Bilous M, Grierson JM, Liddle C. (1995): Coinfection with hepatitis B and C or B, C and D viruses results in severe chronic liver disease and responds poorly to interferon-α treatment. J Virol Hep 2:29-45.
35. Zignego AL, Barbagli S, Mazzanti R, Foschi M, Rossi S, Laffi G, Buzzelli G, Gentilini P (1991): Therapy of chronic active hepatitis C with α-interferon: Effectiveness and prognostic factors. In Gentilini P, Dianzani MU (eds): "Experimental and Clinical Hepatology." Amsterdam: Excerpta Medica, pp 253-259.
36. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Brechot C (1992): Infection of peripheral mononuclear blood cells by hepatitis C virus. Journal of Hepatology 15:382-386.
37. Zignego AL, Foschi M, Laffi G, Monti M, Careccia G, Romanelli RG, De Majo E, Mazzanti R, Buzzelli G, La Villa G, Gentilini P (1994): "Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. Hepatology 19:577-582.
38. Zignego AL, De Carli M, Monti M, Careccia G, La Villa G, Giannini C, D'Elios MM, Del Prete G, Gentilini P (1995): Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. Journal of Medical Virology 47:58-64.
39. Zignego AL, Ferri C, Monti M, La Civita L, Careccia G, Longonbardo G, Lombardini F, Bombardieri S, Gentilini P (1996): Hepatitis C virus genotype analysis in patients with type II mixed cryioglobulinemia. Annals of Internal Medicine 124:31-34.